Very early onset perinatal constipation: Can it be cow's milk protein allergy?

Rajalakshmy Arakoni1, Hebat Kamal2, Sam Xianjun Cheng3

  • 1Department of Pediatrics, University of Florida Shands Children's Hospital, Gainesville, FL 32608, United States.

PubMed

Insights

Perinatal constipation may signal cow's milk protein allergy (CMPA), an often overlooked cause. Early diagnosis and dietary changes can resolve symptoms, potentially avoiding invasive tests for conditions like Hirschsprung's disease.

Area of Science:

  • Pediatrics
  • Allergy Immunology
  • Gastroenterology

Background:

  • Delayed meconium passage or constipation in newborns often prompts investigation for serious conditions like Hirschsprung's disease (HD) and meconium ileus.
  • Diagnosing HD typically requires invasive procedures such as anorectal manometry or rectal suction biopsy.
  • Cow's milk protein allergy (CMPA) is a common infant condition, but symptoms can manifest from birth due to in-utero allergen exposure.

Purpose of the Study:

  • To explore Cow's Milk Protein Allergy (CMPA) as an atypical cause of perinatal constipation.
  • To propose non-invasive diagnostic and management strategies for CMPA-induced perinatal constipation.
  • To evaluate the potential for avoiding invasive testing in cases of perinatal constipation.

Main Methods:

  • Literature review on CMPA presentation in neonates.
  • Analysis of atypical presentations of CMPA, focusing on constipation.
  • Discussion of dietary elimination as a diagnostic and therapeutic tool.

Main Results:

  • CMPA can present atypically with perinatal constipation, rather than classic symptoms like diarrhea or bloody stools.
  • Maternal dietary exposure to cow's milk protein may lead to in-utero sensitization and early-onset symptoms in infants.
  • Dietary elimination of cow's milk protein can lead to rapid symptom improvement in affected infants.

Conclusions:

  • CMPA should be considered in the differential diagnosis of perinatal constipation.
  • Non-invasive dietary modification for CMPA offers a safe alternative to invasive testing for certain cases of neonatal constipation.
  • Implementing a diagnostic pathway that prioritizes ruling out CMPA may prevent unnecessary invasive procedures.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
179
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.3K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
339
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
348
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
262
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
197